Abstract
390 patients with severe head injuries were treated with phenobarbital (PB) orally for a period of 12 months in order to determine whether this drug could reduce the incidence of posttraumatic epilepsy (PTE). An intramuscular PB dose of 2.5–3 mg/kg body weight per day was administered within 24 hours after the trauma; after 5 days, or longer if the coma persisted, the drug was administered orally. Maintenance dosage adjustments, when necessary, were based on serial plasma concentrations of the drug, sustained at between 5 and 30 μg/ml.
293 patients completed the study. 66% of these presented one risk factor, while 34% presented two or more.
6 patients (2.04%) had at least one seizure during the twelve months. Plasma drug levels at the time of the seizure, with one exception of 15 μg/ml, ranged from 20 to 28 μg/ml.
The results of the study indicate that PB administered during the first twelve months after the trauma, even at relatively low doses, can have a prophylactic effect on PTE.
Sommario
390 pazienti con gravi traumi cranici sono stati trattati con phenobarbital (PB) per via orale, per un periodo di 12 mesi, al fine di verificare se tale farmaco potesse ridurre l'incidenza dell'epilessia post-traumatica (PTE). Il PB è stato somministrato per via intramuscolare, entro 24 ore dopo il trauma, alla dose di 2.5–3 mg/kg/die; dopo 5 giorni o un periodo di tempo maggiore se il coma persisteva, il farmaco è stato somministrato per via orale. Il mantenimento del livello plasmatico, quando necessario, è stato ottenuto monitorando le concentrazioni plasmatiche del farmaco che sono state mantenute tra 5 e 30 μg/ml.
293 pazienti hanno completato lo studio. Il 66% presentava un solo fattore di rischio, mentre il 34% presentava due o più fattori di rischio associati.
6 pazienti (2.04%) hanno presentato almeno una crisi epilettica entro i 12 mesi. I livelli plasmatici del farmaco al momento della crisi, variavano fra 20 e 28 μg/ml, con una eccezione di 15 μg/ml. I risultati dello studio indicano che il PB somministrato durante i primi 12 mesi dopo il trauma, anche a dosi relativamente basse, può avere un effetto profilattico sulla PTE.
Similar content being viewed by others
References
Annegers J.F., Grabow J.D., Groover R.V. et al.:Seizures after head trauma: a population study. Neurology 30:683–689, 1980.
Antony J.H., Hawke S.H.B.:Phenobarbital compared with carbamazepine in prevention of recurrent febrile convulsions. Am. J. Dis. Child. 137:892–895, 1983.
Bacon C.J., Mucklow J.C., Rawlins M.D. et al.:Placebo-controlled study of phenobarbitone and phenytoin in the prophylaxis of febrile convulsions. Lancet 2:600–604, 1981.
Caveness W.F., Walker A.E., Ascroft P.B.:Incidence of posttraumatic epilepsy in Korean veterans as compared with those from World War I and World War II. J. Neurosurg. 19:122–129, 1962.
De Santis A., Rampini P., Ravagnati L. et al.:Profilassi anticomiziale in neurochirurgia. Boll. Lega It. Epil. 62/63:231–233, 1988.
Glötzner F.L., Haubitz I., Miltner F. et al.:Anfallsprophylaxe mit Carbamazepin nach schweren Schadelhirnverletzungen. Neurochirurgia 26:66–79, 1983.
Jennett W.B.:Epilepsy after non-missile head injuries. 2nd ed. London: Heinemann Medical Books, 1975 p. 179.
McQueen J.K., Blackwood D.H.R., Harris P. et al.:Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis. J. Neurol. Neurosurg. Psychiatry 46:899–904, 1983.
Murri L., Parenti G., Bonuccelli U. et al.:Phenobarbital prophylaxis of posttraumatic epilepsy. Ital. J. Neurol. Sci. 4:225–230, 1980.
Mutani R., Monaco F., Cantello R. et al.:Pharmacological Prophylaxis of Posttraumatic Epileptogenesis: An Update On The Experimental Models. In Murri L., Parenti G., Annegers J.F., (eds). “Pharmacological Prophylaxis for Posttraumatic Epilepsy”. Pisa, Pacini, pp. 17–21, 1991.
Penfield W., Shaver M.:The incidence of traumatic epilepsy and headache after head injury in civil practice. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 24:620–634, 1945.
Popek K., Musil F.:Clinical trial to prevent posttraumatic epilepsy after severe brain injures in adults. Cas. lek. ces. 108:133–147, 1969.
Rapport R.L., Penry J.K.:A survey of attitudes toward the pharmacological prophylaxis of posttraumatic epilepsy. J. Neurosurg. 38:159–166, 1973.
Rapport R.L., Penry J.K.:Parmacologic Prophylaxis of Posttraumatic Epilepsy. A Review. Epilepsia 13:295–304, 1972.
Salazar A.M., Jabbari B., Vance S.C. et al.:Epilepsy after penetrating head injury. I. Clinical correlates: A report of the Vietnam Head Injury Study. Neurology 35:1406–1414, 1985.
Servit Z., Musil F.:Prophylactic treatment of posttraumatic epilepsy: Results of a long-term follow-up in Czechoslovakia. Epilepsia 22:315–320, 1981.
Temkin N.R., Dikmen S.S., Wilensky A.J. et al.:A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N. Engl. J. Med. 323:497–502, 1990.
Wohns R.N.W., Wyler A.R.:Prophylactic phenytoin in severe head injuries. J. Neurosurg. 51:507–509, 1979.
Young B., Rapp R., Brooks W.H. et al.:Posttraumatic epilepsy prophylaxis. Epilepsia 20:671–681, 1979.
Young B., Rapp R., Norton J.A. et al.:Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J. Neurosurg. 58:236–241, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murri, L., Arrigo, A., Bonuccelli, U. et al. Phenobarbital in the prophylaxis of late posttraumatic seizures. Ital J Neuro Sci 13, 755–760 (1992). https://doi.org/10.1007/BF02229161
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02229161